1. 96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects. Issue 1 (February 2015) Authors: Porter, Danielle P.; Kulkarni, Rima; Fralich, Todd; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 16:Issue 1(2015) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ALVR109, an off‐the‐shelf partially HLA matched SARS‐CoV‐2–specific T cell therapy, to treat refractory severe COVID‐19 pneumonia in a heart transplant patient: Case report. Issue 4 (27th December 2021) Authors: Martits‐Chalangari, Katalin; Spak, Cedric W.; Askar, Medhat; Killian, Aaron; Fisher, Tammy L.; Atillasoy, Ercem; Marshall, William L.; McNeel, David; Miller, Michael D.; Mathai, Susan K.; Gottlieb, Robert L. Journal: American journal of transplantation Issue: Volume 22:Issue 4(2022) Page Start: 1261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline Antiretroviral Resistance Mutations and Treatment-Emergent Resistance in HIV-1 RNA-Suppressed Patients Switching to EVG/COBI/FTC/TDF or Continuing on Their PI-, NNRTI-, or RAL-Based Regimen. (15th April 2015) Authors: Andreatta, Kristen; Kulkarni, Rima; Abram, Michael E.; Nguyen, Thai; Cao, Huyen; Miller, Michael D.; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 68:Number 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Issue 2 (15th December 2014) Authors: Hedskog, Charlotte; Doehle, Brian; Chodavarapu, Krishna; Gontcharova, Viktoria; Crespo Garcia, Javier; De Knegt, Robert; Drenth, Joost P.H; McHutchison, John G.; Brainard, Diana; Stamm, Luisa M.; Miller, Michael D.; Svarovskaia, Evguenia; Mo, Hongmei Journal: Hepatology Issue: Volume 61:Issue 2(2015:Feb.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study*. Issue 1 (2nd January 2016) Authors: Porter, Danielle P.; Toma, Jonathan; Tan, Yuping; Solberg, Owen; Cai, Suqin; Kulkarni, Rima; Andreatta, Kristen; Lie, Yolanda; Chuck, Susan K.; Palella, Frank; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 17:Issue 1(2016) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide. (30th January 2017) Authors: Margot, Nicolas A.; Wong, Pamela; Kulkarni, Rima; White, Kirsten; Porter, Danielle; Abram, Michael E.; Callebaut, Christian; Miller, Michael D. Journal: Journal of infectious diseases Issue: Volume 215:Number 6(2017:Mar. 15) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV. Issue 9 (1st May 2017) Authors: Schreier, John D.; Embrey, Mark W.; Raheem, Izzat T.; Barbe, Guillaume; Campeau, Louis-Charles; Dubost, David; McCabe Dunn, Jamie; Grobler, Jay; Hartingh, Timothy J.; Hazuda, Daria J.; Klein, Daniel; Miller, Michael D.; Moore, Keith P.; Nguyen, Natalie; Pajkovic, Natasa; Powell, David A.; Rada, V... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 9(2017) Page Start: 2038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild‐type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF. Issue 9 (23rd May 2014) Authors: Liu, Yang; Fung, Scott; Gane, Edward J.; Dinh, Phillip; Flaherty, John F.; Svarovskaia, Evguenia S.; Miller, Michael D.; Kitrinos, Kathryn M. Journal: Journal of medical virology Issue: Volume 86:Issue 9(2014:Sep.) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D. (20th November 2013) Authors: Liu, Yang; Miller, Michael D.; Kitrinos, Kathryn M. Journal: Liver international Issue: Volume 34:Number 7(2014:Sep.) Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate. (1st September 2018) Authors: Andreatta, Kristen; Chang, Silvia; Martin, Ross; Acosta, Rima; Daeumer, Martin; Thielen, Alexander; Miller, Michael D.; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 79:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗